about
Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary SyndromeCoordinated collagen and muscle protein synthesis in human patella tendon and quadriceps muscle after exerciseFrom hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokinesEffects of growth hormone treatment on serum levels of insulin-like growth factors (IGFs) and IGF binding proteins 1-4 in postmenopausal womenThyroid function in Danish greenhouse workersDevelopmental changes in serum levels of free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in ratsEffects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosisThe role of the complement system in diabetic nephropathy.Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects.A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization studyHomologous growth hormone accelerates healing of segmental bone defects.Reduced free IGF-I and increased IGFBP-3 proteolysis in Turner syndrome: modulation by female sex steroids.Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats.High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.Prognostic value of chromogranin A in chronic heart failure: data from the GISSI-Heart Failure trial.Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview.Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections.Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes.The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.Exercise-dependent IGF-I, IGFBPs, and type I collagen changes in human peritendinous connective tissue determined by microdialysis.Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa.Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers.Prevention and early detection of vascular complications of diabetesEffects of ischemic pre- and postconditioning on HIF-1α, VEGF and TGF-β expression after warm ischemia and reperfusion in the rat liverBody mass index is related to microvascular vasomotion, this is partly explained by adiponectin.Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colonClinical review 166: Growth hormone receptor antagonists.The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.Octreotide and diabetes: theoretical and experimental aspects.Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: lessons from experimental rodent models.The involvement of growth hormone (GH), insulin-like growth factors (IGFs) and vascular endothelial growth factor (VEGF) in diabetic kidney disease.Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes modelInvestigation of metabolic changes in STZ-induced diabetic rats with hyperpolarized [1-13C]acetate.Complement activation and diabetic vascular complications.Antioxidant treatment attenuates lactate production in diabetic nephropathy.The role of growth hormone in the pathogenesis of diabetic kidney disease.Inhibition and reversibility of renal changes: lessons from diabetic kidney disease.
P50
Q26780488-8839B67B-E3BD-45B4-8C9E-630F74A9FDC3Q28260402-419E1EDA-26E7-4532-9542-D4A424AEDE7AQ28297006-08B40842-2893-4970-AF18-CFBE289CF48EQ28373650-6C87B5A1-ADA3-4CF4-A6BA-E63363D91712Q28392745-087A1AB6-95FD-40C1-AAAA-34A68B99612BQ28576775-FD1F4FCA-90D2-43F6-B51B-845256EC72B1Q28578034-0E394124-13D1-4134-8371-0557E712AFE2Q30235417-FBAE42A3-C720-4EAD-A0E6-3ACC8E62C9FFQ30434315-AC78543D-AE74-4650-96C9-14AD914BCE1BQ30437335-C47020A9-F825-40D4-B53E-A7AF0419867CQ30538088-27A17B24-9338-477B-847D-F7BF43674449Q31015440-F1131856-DD59-415A-9DEB-89E8A06597E4Q31833546-11CB6268-55D8-4E33-A161-EDADBD01A420Q33203981-757CD0D7-704D-4210-B817-7926BA480E09Q33460332-7635ACF6-93D6-4DFA-905F-FE5988CA58FFQ33554096-0060BB16-070D-4D77-9C18-1D28491AE0CFQ33917790-9F0DBEBA-A7D8-45AB-978C-05FD26C893DCQ34391615-4482EED8-A23B-44AD-9D2C-F863E3D58A7EQ34429278-824AECA4-4925-46E3-B1C3-0BE211B4CC1CQ34474453-3F4D40F8-F6B4-4F53-B2FC-99221534526DQ34566221-E83736F4-4084-4059-A5C1-7259B4A53FACQ34612843-2A5D0D25-80EF-4D27-9CD7-9B6D1EF27FB8Q34655118-562F0699-34D9-47C9-8686-10CA5FCB7451Q34795311-C603E7E0-EB60-4F2C-9763-58CBC3E7EFB3Q35013431-165D9DE6-A11E-4C23-9148-AFD24125D5A5Q35163822-6CD26D1F-F1BF-4F1B-A9D5-34272E2BC56BQ35172921-DDD34E0F-5110-4644-8877-36D91F0C9576Q35354921-FC26FDBE-1645-4690-8B82-A92F8249E15FQ35740727-1441A40D-A941-427C-B094-AAD8C1FDE15BQ35776377-BEF33633-CC4A-48E0-8BF5-3429FE4B295CQ35796678-CD058EE8-C661-4BC8-B885-B00BB8144396Q35926521-53F96BC9-59BE-4B04-94ED-E230D7083BCBQ35935318-31191BB6-C88E-47D2-83AA-6B2008EE3B14Q35950302-85B45781-C4DA-440A-889B-94DEC878654EQ35974957-094931A7-9EBD-4311-A067-A92204703664Q36036388-0DC8781B-A2EE-4B40-91F7-FBB79EA2AE56Q36183601-DA50FFE2-1108-4A7A-AFC6-197D402DDDEDQ36245001-69CCE385-1D56-4D17-8E4C-E8110A19692BQ36380811-8A4BFF05-DBEF-4092-8290-340A8149A989Q36486800-0309FC2F-769B-4069-A31D-F14667CF9557
P50
description
onderzoeker
@nl
name
Allan Flyvbjerg
@ast
Allan Flyvbjerg
@da
Allan Flyvbjerg
@de
Allan Flyvbjerg
@en
Allan Flyvbjerg
@es
Allan Flyvbjerg
@fo
Allan Flyvbjerg
@fr
Allan Flyvbjerg
@is
Allan Flyvbjerg
@kl
Allan Flyvbjerg
@nb
type
label
Allan Flyvbjerg
@ast
Allan Flyvbjerg
@da
Allan Flyvbjerg
@de
Allan Flyvbjerg
@en
Allan Flyvbjerg
@es
Allan Flyvbjerg
@fo
Allan Flyvbjerg
@fr
Allan Flyvbjerg
@is
Allan Flyvbjerg
@kl
Allan Flyvbjerg
@nb
prefLabel
Allan Flyvbjerg
@ast
Allan Flyvbjerg
@da
Allan Flyvbjerg
@de
Allan Flyvbjerg
@en
Allan Flyvbjerg
@es
Allan Flyvbjerg
@fo
Allan Flyvbjerg
@fr
Allan Flyvbjerg
@is
Allan Flyvbjerg
@kl
Allan Flyvbjerg
@nb
P1006
P214
P1006
P106
P2002
allanflyvbjerg
P21
P214
P31
P6634
allan-flyvbjerg-03b85813
P735
P7859
lccn-n92804069